Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Submitted by
admin
on February 3, 2025 - 11:55am
Source:
Motley Fool
News Tags:
Novo Nordisk
obesity
amycretin
Headline:
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
snippet:
Novo Nordisk reported strong data for its next-gen anti-obesity medicine.
The Danish company has an excellent weight loss drug pipeline.
But it's also diversifying its lineup and offering other perks.
Do Not Allow Advertisers to Use My Personal information
